Skip to Main Content

November 05, 2021

Health Law Weekly

FDA, CDC Clear Pfizer COVID-19 Vaccine for Children Ages 5-11

  • November 05, 2021

About 28 million children in the United States can now receive the COVID-19 vaccine after Centers for Disease Control and Prevention Director Rochelle P. Walensky, M.D., M.P.H., endorsed November 2 an independent advisory panel recommendation to allow the Pfizer-BioNTech shot for the 5 to 11 age group.

The move follows the Food and Drug Administration’s (FDA’s) decision on October 29 to approve emergency use authorization for the two-dose Pfizer vaccine, which will be administered in lower doses to children.

The Centers for Medicare & Medicaid Services also reminded consumers that COVID-19 vaccinations are available to children ages 5 through 11 without cost-sharing under Medicare, Medicaid, the Children’s Health Insurance Program, and in the commercial market.  

 

ARTICLE TAGS
  • Coronavirus Pandemic